## Abstract Imatinib is standard firstβline treatment for patients with advanced gastrointestinal stromal tumor (GIST). Initial responses are not always accompanied by reductions in tumor size; consequently, other parameters should be considered in response assessments. Conventional sizeβbased crit
β¦ LIBER β¦
Molecular response prediction in gastrointestinal stromal tumors
β Scribed by Philippe A. Cassier; Jean-Yves Blay
- Book ID
- 107384374
- Publisher
- Springer-Verlag
- Year
- 2010
- Tongue
- English
- Weight
- 176 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1776-2596
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Response assessment in gastrointestinal
β
Jayesh Desai
π
Article
π
2011
π
John Wiley and Sons
π
French
β 475 KB
Molecular markers predictive of response
β
Vincenzo Catalano; Anna Maria Baldelli; Paolo Giordani; Stefano Cascinu
π
Article
π
2001
π
Elsevier Science
π
English
β 119 KB
Gastrointestinal cancers account for a large amount of human tumors. Surgery is the standard treatment for localized gastrointestinal cancer, but in a large number of patients, tumors are unresectable at time of diagnosis and even when resectable, survival is often poor. Current attempts to improve
Predictive markers of KIT inhibition in
β
Derron E. Allen; Martin J. Heslin; Takahiro Taguchi; Juan P. Arnoletti; Andrey F
π
Article
π
2009
π
Elsevier Science
π
English
β 85 KB
Gastrointestinal Stromal Tumors II: Medi
β
Robert S. Benjamin; Maria Debiec-Rychter; Axel Le Cesne; Stefan Sleijfer; George
π
Article
π
2009
π
Elsevier Science
π
English
β 696 KB
Computed tomography in gastrointestinal
β
Nadir Ghanem; Carsten Altehoefer; Alex FurtwΓ€ngler; Jan Winterer; Oliver SchΓ€fer
π
Article
π
2003
π
Springer
π
English
β 558 KB
Maspin expression in gastrointestinal st
β
Saduman Balaban Adim; Gulaydan Filiz; Ozkan Kanat; Omer Yerci; Halil Ozguc; Bern
π
Article
π
2010
π
BioMed Central
π
English
β 803 KB